Cécile Vernant is head of EU advocacy for Deutsche Stiftung Weltbevölkerung, an international development and advocacy organization focused on achieving universal access to sexual and reproductive health and rights. Representing DSW in Brussels, Cécile focuses on global health, SRHR, and youth and women empowerment. Prior to joining DSW, she worked in EU public affairs as well as corporate marketing and crisis communication in her native France and the United States.
Europe has an opportunity in 2017 to position itself as the champion of global health innovation during a review of its seven-year budget, identifying spending and research priorities for the next three years. Cécile Vernant, head of EU advocacy for Deutsche Stiftung Weltbevoelkerung, explores three ways Europe can grasp this opportunity.
Immunization saves millions of lives annually. But to continue successful treatments, the global health sector must expand the R&D agenda to fund the next generation of lifesaving vaccines. Cecile Vernant of DSW offers three ways to harness the latent potential in vaccine research.
This week's World Health Assembly is serving up a packed agenda for global health policymakers in Geneva. In this exclusive opinion, the head of EU advocacy for DSW gives us her take on three key issues to watch closely.